This is being filed to report the thrombus.It was reported that this was a mitraclip procedure to treat functional mitral regurgitation (mr) with a grade of 4.Five minutes after the steerable guide catheter (sgc) inserted into the groin, and the dilator and guide wire were retracted, while aspirating the sgc, a thrombus was noted at the hemostasis valve.The physician attempted to aspirate the thrombus but was unsuccessful the thrombus stayed in the hemostasis valve and was stable there but the risk to mobilize it was too high.Therefore, the sgc was removed and exchanged for a new sgc.After the first sgc was removed, there was no evidence of thrombus or something similar inside the patients heart or any other structure.The patient had heparin for bridging medication as an anticoagulation prior to the procedure.Activated clotting time (act) was 268 at the time when the thrombus was noted.One clip was implanted, reducing mr to 1-2.No additional information was provided.
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.Based on the available information, a cause for the reported thrombosis could not be determined.The reported patient effect of thrombosis is listed in the mitraclip system instructions for use (ifu), and is a known possible complication associated with mitraclip procedures.The reported additional therapy/non-surgical treatment and treatment with medication were results of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design or labeling.Na.
|